Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS, BFA, FVT

Jolly Good Revolutionizes Healthcare with Immersive Service for Apple Vision Pro, Premiering at SXSW 2024


A Milestone Entry into Spatial Computing Healthcare

BROOKLINE, Mass., Feb. 22, 2024 /PRNewswire/ -- Jolly Good US Inc. proudly presents "JOLLYGOOD+ for Vision Pro," a groundbreaking immersive medical service harnessing the power of spatial computing through Apple Vision Pro technology. This innovative leap forward enables us to transcend the limitations of conventional VR, ushering in a new era of immersive medical training and healthcare services.

Furthermore, we're thrilled to announce the imminent release of our dedicated app on the App Store in early March 2024. The anticipation builds as we prepare to unveil this groundbreaking service for the very first time at SXSW Creative Industries Expo 2024 in Austin, Texas.

Drawing from our extensive experience in delivering cutting-edge medical education and healthcare services leveraging VR x AI technology to nations worldwide, we're proud to unveil "JOLLYGOOD+ for Vision Pro." Built upon the foundational concept of spatial computing, this service represents a significant advancement in healthcare delivery, seamlessly bridging the virtual and real worlds to provide a stress-free, intelligent, and efficient healthcare experience.

With a proven track record of implementation and development at esteemed medical institutions, medical device manufacturers, and pharmaceutical companies, Jolly Good stands as a trusted partner in revolutionizing healthcare. Dive deeper into the immersive world of "JOLLYGOOD+ for Vision Pro" by watching our promotional movie. https://youtu.be/nD2uFEl73Lk

Jolly Good Revolutionizes Healthcare with Immersive Service for Apple Vision Pro, Premiering at SXSW 2024

Discover "JOLLYGOOD+ for Vision Pro" at SXSW Creative Industries Expo 2024

Join Us as Development Partners

Jolly Good is actively seeking collaboration with effectiveness verification partners from diverse medical-related institutions to promote and validate the compatibility of medical VR with Apple Vision Pro. Additionally, we are inviting potential joint development partners to enhance the value of our immersive healthcare experience. For inquiries, please click here:

https://jollygoodinc.com/contact

About Jolly Good Inc.

Jolly Good, a distinguished medical technology company hailing from Japan, specializes in the development of high-precision VR solutions and innovative medical and welfare services powered by AI, which meticulously analyzes user behavior within VR environments. Establishing Jolly Good US Inc. in 2023 marked our commitment to global expansion and pioneering advancements in healthcare technology.

Currently, we are engaged in collaborative joint development endeavors with prestigious institutions such as Harvard University and Boston University in the United States, as well as Mahidol University in Thailand. 

Our mission encompasses a broad spectrum of initiatives, ranging from advancing medical education to innovating treatments for mental illness and providing support for employment opportunities. To learn more about our initiatives and contributions to the advancement of healthcare, please visit us at https://jollygoodinc.com/ 

SOURCE Jolly Good US Inc.


These press releases may also interest you

at 22:17
Dr. Scott McMahon of Whole World Health Care is happy to announce the 2024 annual Surviving Mold-CIRSx Conference, set to be held May 16-19, 2024 at the Hyatt Regency, located at 2615 Preston Road in Frisco, Texas, a city near Dallas. CIRSx was...

at 20:16
PDS Health®, a leading U.S. provider of integrated healthcare support services, proudly announces its recognition as one of The Civic 50 honorees of 2024 by Points of Light, the world's largest nonprofit dedicated to accelerating people-powered...

at 20:12
Note: All times local Quebec City, Quebec 9:30 a.m. The Prime Minister will take part in an historic announcement about the Québec Bridge. The Minister of Public Services and Procurement, Jean-Yves Duclos, and the Minister of Transport and Quebec...

at 19:35
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...

at 19:34
Andlauer Healthcare Group Inc. ("AHG" or the "Company") today announced that the Board has approved a substantial issuer bid (the "Offer") under which the Company will offer to purchase for cancellation up to 2,000,000 subordinate voting shares of...

at 19:30
The global electrophysiology market  size is estimated to grow by USD 6.09 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.71%  during the forecast period. ...



News published on and distributed by: